CLINICAL_TRIALS
trial_result
· 2022-12-02
Clinical Trial Update: A Factor IX Gene Therapy Study (FIX-GT) [Phase 1, Phase 2]
Summary
A phase 1/2 clinical trial of a Factor IX gene therapy (FIX-GT) for Hemophilia B was terminated; results were posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University College, London | Conditions: Hemophilia B | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-12-02